Medigen to hold small Phase 3 trial of its COVID-19 vaccine in Paraguay
07/20/2021 07:01 PM
Medigen Vaccine Biologics Corp. announced Tuesday that it has received permission to hold a 1,000-person Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, which was granted emergency use authorization (EUA) in Taiwan the day before.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Black pepper recalled in New Taipei due to dye contamination
04/28/2024 08:12 PM - Cross-Strait
Taiwan lukewarm about China's eased rules on travel to Matsu
04/28/2024 06:16 PM - Society
Food poisoning cases from Kaohsiung buffet rise to 46
04/28/2024 05:46 PM - Society
Disaster relief donations in wake of Hualien quake top NT$1 billion
04/28/2024 05:18 PM - Society
Experts urge better labor rights protections ahead of Taiwan-U.S. talks
04/28/2024 03:24 PM